Yüksel Selçuk, Oztürk Burcu, Kavaz Asli, Ozçakar Z Birsin, Acar Banu, Güriz Haluk, Aysev Derya, Ekim Mesiha, Yalçinkaya Fatoş
Department of Pediatric Nephrology, Ankara University School of Medicine, Ankara, Turkey.
Int J Antimicrob Agents. 2006 Nov;28(5):413-6. doi: 10.1016/j.ijantimicag.2006.08.009. Epub 2006 Sep 26.
The changing pattern of antimicrobial resistance in the causative microorganisms of urinary tract infection (UTI) in childhood is a growing problem. The aims of this study were to assess the resistance patterns of urinary isolates to commonly used antimicrobials and to evaluate the options for empirical treatment of UTI. A prospective cross-sectional analysis of bacteria isolated from children with UTI was performed between January 2003 and January 2004. Resistance to antibiotics was analysed in three age groups: Group I, < or =12 months; Group II, 13-60 months; and Group III, >60 months. A total of 165 urinary pathogens were isolated from 131 patients. Mean patient age was 63.7+/-49.8 months. The most common causative agent was Escherichia coli (87% of cases) followed by Klebsiella pneumoniae (10%). Resistance to ampicillin (74.2%) and co-trimoxazole (61.3%) was significant in all isolates. Nitrofurantoin was the most active agent against E. coli (2.2% resistant isolates), followed by amikacin (4.9%), ceftriaxone (7.5%) and ciprofloxacin (12%). None of the isolates from Group I patients were resistant to ciprofloxacin and a low resistance rate (7.1%) was noted for amikacin. In Group II patients, none of the isolates were resistant to amikacin, and ceftriaxone was the second most suitable antibiotic (resistance rate 2.2%). In Group III patients, the lowest resistance rate was against nitrofurantoin (2.7%). In conclusion, we observed that the use of ampicillin and co-trimoxazole as a single agent for empirical treatment of a suspected UTI would not cover the majority of urinary pathogens in our region. Whilst amikacin, with a negligible resistance rate, was suitable in all age groups, gentamicin might still be useful as an empirical treatment of UTI in children aged >1 year. Nitrofurantoin could be included as a reasonable alternative in the empirical treatment of lower UTI in older children.
儿童尿路感染(UTI)致病微生物中抗菌药物耐药性模式的变化是一个日益严重的问题。本研究的目的是评估尿液分离株对常用抗菌药物的耐药模式,并评估UTI经验性治疗的选择。2003年1月至2004年1月期间,对UTI患儿分离出的细菌进行了前瞻性横断面分析。分析了三个年龄组对抗生素的耐药性:第一组,≤12个月;第二组,13 - 60个月;第三组,>60个月。共从131例患者中分离出165种尿路病原体。患者平均年龄为63.7±49.8个月。最常见的病原体是大肠埃希菌(87%的病例),其次是肺炎克雷伯菌(10%)。所有分离株对氨苄西林(74.2%)和复方新诺明(61.3%)的耐药性显著。呋喃妥因是对大肠埃希菌最有效的药物(2.2%的耐药分离株),其次是阿米卡星(4.9%)、头孢曲松(7.5%)和环丙沙星(12%)。第一组患者的分离株对环丙沙星均无耐药性,阿米卡星的耐药率较低(7.1%)。在第二组患者中,分离株对阿米卡星均无耐药性,头孢曲松是第二合适的抗生素(耐药率2.2%)。在第三组患者中,对呋喃妥因的耐药率最低(2.7%)。总之,我们观察到,使用氨苄西林和复方新诺明作为单一药物对疑似UTI进行经验性治疗,无法覆盖我们地区的大多数尿路病原体。虽然阿米卡星的耐药率可忽略不计,适用于所有年龄组,但庆大霉素可能仍可作为1岁以上儿童UTI经验性治疗的药物。呋喃妥因可作为较大儿童下尿路感染经验性治疗的合理替代药物。